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Active Bacterial Core Surveillance (ABCs) Report
Emerging Infections Program Network
Neisseria meningitidis, 2000
ABCs Areas
California (3 county San Francisco Bay area); Connecticut;
Georgia; Maryland; Minnesota; New York (15 county
Rochester/Albany area); Oregon; Tennessee (11 countyarea).
ABCs Population
The surveillance areas represent 33,327,077 persons.
Source: U.S. Bureau of the Census, 2000
ABCs Case Definition
Invasive meningococcal disease: isolation of Neisseria
meningitidis from normally sterile site in a resident of a
surveillance area in 2000.
ABCs Methodology
Project personnel communicated at least monthly with
contacts in all microbiology laboratories serving acute care
hospitals in their area to identify cases. Standardized case
report forms that include information on demographic
characteristics, clinical syndrome, and outcome of illness
were completed for each identified case. Molecular subtyping
was done on meningococcal isolates at CDC. Regular
laboratory audits assess completeness of active surveillance
and detect additional cases.
All rates of invasive meningococcal disease were calculated
using U.S. Bureau of the Census population estimates for
2000.
For national projections of cases, race- and age-specific rates
of disease were applied from the aggregate surveillance area
to the age and racial distribution of the 2000 U.S. population.
Cases with unknown race were distributed by area based on
reported race distribution for known cases within the eight
age categories.
Reported ABCs Profiles
Race No. (Rate*)
White 196 (0.8)
Black 51 (0.9)
Other 12 (0.4)
Total 259 (0.8)
Unknown race (n=41) distributed among knowns
*Cases per 100,000 population for ABCs areas.
Cases Deaths
Syndrome No. (%*) No. (Rate†)
Meningitis 132 (51.2) 16 (12.1)
Bacteremia w/o focus 89 (34.5) 11 (12.4)
*Percent of cases. †Deaths per 100 cases with known outcome
Age
(years)
Serogroups
B C Y Other
No. (Rate*) No. (Rate) No. (Rate) No. (Rate)
<1 18 (4.0) 1 (0.2) 8 (1.8) 7 (1.6)
1 11 (2.5) 0 (0.0) 3 (0.7) 2 (0.5)
2-4 12 (0.9) 2 (0.2) 1 (0.1) 2 (0.2)
5-17 25 (0.4) 9 (0.1) 12 (0.2) 3 (0.05)
18-34 23 (0.3) 11 (0.1) 10 (0.1) 14 (0.2)
35-49 3 (0.04) 8 (0.1) 9 (0.1) 4 (0.05)
50-64 6 (0.1) 1 (0.02) 11 (0.2) 4 (0.1)
>65 4 (0.1) 9 (0.2) 19 (0.5) 7 (0.2)
Total 102 (0.3) 41 (0.1) 73 (0.2) 43 (0.1)
* Cases per 100,000 population for ABCs areas
National Projection for Invasive Disease:
Cases: 2,200 (0.8/100,000)
Deaths: 300 (0.1/100,000)
Healthy People 2010 Update:
Objective: Reduce the incidence of invasive meningococcal
disease to 0.9 per 100,000 population.
2010 Objective 2000 Rate*
0.9/100,000 0.8/100,000
*Cases per 100,000 U.S. population.
Source: ABCs/NETSS
For more information, visit our web site at:
http://www.cdc.gov/abcs
